With a global workforce of approximately 40,000 employees (8,000 R&D), the primary focus is in Diabetes, Oncology, ,Neurodegeneration, Auto Immune, & Pain therapeutic areas.
The largest affiliate outside of the United States is in Japan with roughly 3,300 workers.
Successfully conducting clinical trials and introducing new products in Japan and drug safety monitoring activities, it will further lead the Medical Affairs business. As a member of the development medical team , which is expanding globally, it is expected to be active on a global level, such as participating in the global strategy. Focus areas will be breast & lung cancer.
Real Staffingについてもっと詳しく知りたい方はこちらへ→ www.apac.realstaffing.com/ja